Back to Results
First PageMeta Content
Sulfonamides / Chemistry / Organic chemistry / Isoxazoles / Valdecoxib / Rofecoxib / Celecoxib / Off-label use / Food and Drug Administration / COX-2 inhibitors / Pfizer / Pharmacology


NEWS RELEASE Office of the Attorney General Robert E. Cooper, Jr. Department of Commerce and Insurance Commissioner Leslie Newman
Add to Reading List

Document Date: 2014-10-02 15:26:49


Open Document

File Size: 68,54 KB

Share Result on Facebook

Company

Pfizer Inc. / Cox / Pharmacia / /

Currency

USD / /

Event

Product Issues / Product Recall / /

IndustryTerm

deceptive and misleading advertising / pharmaceutical industry / pharmaceutical manufacturers / direct-to-consumer advertising / /

MedicalCondition

strokes / pain / heart attacks / inflammation / /

Organization

NEWS RELEASE office of the Attorney General Robert E. Cooper / Division of Consumer Affairs / Food and Drug Administration / Department of Commerce / Insurance / /

Person

Robert E. Cooper / Jr. / Leslie Newman / Bob Cooper / Mary Clement / Sharon Curtis-Flair / /

/

Position

TN ATTORNEY / Commissioner / Consumer Affairs Director / physician / ATTORNEY GENERAL / BEXTRA AND CELEBREX Attorney General / /

Product

CELEBREX / Vioxx / Ibuprofen / BEXTRA / Aleve / naproxen / Advil / raised regarding Pfizer’s Cox-2 drug Bextra / /

ProvinceOrState

Tennessee / /

URL

http /

SocialTag